Rubis B - Search Results

1

Telomerase and drug resistance in cancer.

Lipinska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B. Lipinska N, et al. Among authors: rubis b. Cell Mol Life Sci. 2017 Nov;74(22):4121-4132. doi: 10.1007/s00018-017-2573-2. Epub 2017 Jun 16. Cell Mol Life Sci. 2017. PMID: 28623509 Free PMC article. Review.

2

Phytosterols in physiological concentrations target multidrug resistant cancer cells.

Rubis B, Polrolniczak A, Knula H, Potapinska O, Kaczmarek M, Rybczynska M. Rubis B, et al. Med Chem. 2010 Jul;6(4):184-90. doi: 10.2174/1573406411006040184. Med Chem. 2010. PMID: 20843282

3

Human telomerase activity regulation.

Wojtyla A, Gladych M, Rubis B. Wojtyla A, et al. Among authors: rubis b. Mol Biol Rep. 2011 Jun;38(5):3339-49. doi: 10.1007/s11033-010-0439-x. Epub 2010 Nov 18. Mol Biol Rep. 2011. PMID: 21086176 Free PMC article. Review.

4

Human telomerase expression regulation.

Gladych M, Wojtyla A, Rubis B. Gladych M, et al. Among authors: rubis b. Biochem Cell Biol. 2011 Aug;89(4):359-76. doi: 10.1139/o11-037. Epub 2011 Jul 26. Biochem Cell Biol. 2011. PMID: 21790308 Review.

5

The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease.

Toton E, Lisiak N, Rubis B, Budzianowski J, Gruber P, Hofmann J, Rybczynska M. Toton E, et al. Among authors: rubis b. Eur J Pharmacol. 2012 May 5;682(1-3):21-8. doi: 10.1016/j.ejphar.2012.02.020. Epub 2012 Feb 21. Eur J Pharmacol. 2012. PMID: 22381066 Free PMC article.

6

Telomerase as a useful target in cancer fighting-the breast cancer case.

Holysz H, Lipinska N, Paszel-Jaworska A, Rubis B. Holysz H, et al. Among authors: rubis b. Tumour Biol. 2013 Jun;34(3):1371-80. doi: 10.1007/s13277-013-0757-4. Epub 2013 Apr 5. Tumour Biol. 2013. PMID: 23558965 Free PMC article. Review.

7

Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner.

Rubis B, Holysz H, Gladych M, Toton E, Paszel A, Lisiak N, Kaczmarek M, Hofmann J, Rybczynska M. Rubis B, et al. Mol Biol Rep. 2013 Aug;40(8):4995-5004. doi: 10.1007/s11033-013-2600-9. Epub 2013 May 16. Mol Biol Rep. 2013. PMID: 23677713 Free PMC article.

8

Telomerase modulation in therapeutic approach.

Romaniuk A, Kopczynski P, Ksiazek K, Rubis B. Romaniuk A, et al. Among authors: rubis b. Curr Pharm Des. 2014;20(41):6438-51. doi: 10.2174/1381612820666140630092721. Curr Pharm Des. 2014. PMID: 24975610 Review.

9

Telomere shortening in Down syndrome patients--when does it start?

Gruszecka A, Kopczyński P, Cudziło D, Lipińska N, Romaniuk A, Barczak W, Rozwadowska N, Totoń E, Rubiś B. Gruszecka A, et al. Among authors: rubis b. DNA Cell Biol. 2015 Jun;34(6):412-7. doi: 10.1089/dna.2014.2746. Epub 2015 Mar 18. DNA Cell Biol. 2015. PMID: 25786194 Free PMC article.

10

Proapoptotic activity and ABCC1-related multidrug resistance reduction ability of semisynthetic oleanolic acid derivatives DIOXOL and HIMOXOL in human acute promyelocytic leukemia cells.

Paszel-Jaworska A, Rubiś B, Bednarczyk-Cwynar B, Zaprutko L, Rybczyńska M. Paszel-Jaworska A, et al. Among authors: rubis b. Chem Biol Interact. 2015 Dec 5;242:1-12. doi: 10.1016/j.cbi.2015.07.011. Epub 2015 Sep 8. Chem Biol Interact. 2015. PMID: 26362502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page